News

Alto Neuroscience CFO sells $3.57 million in shares

Finance

Alto Neuroscience CFO sells $3.57 million in shares

6 sourcesUpdated Oct 4, 20261 min read

0

Alto Neuroscience CFO sells $3.57 million in shares — © IJR

Sponsored

Alto Neuroscience President and CFO Nicholas Conrad Smith sold 134,886 shares for about $3.57 million in transactions on September 29 and 30, 2026. The sales were made under a Rule 10b5-1 trading plan adopted in June, and included shares sold after Smith exercised employee stock options. Following the transactions, Smith directly held 24,060 shares.

Sponsored

In this story:SEC Rule 10b5-1

Where do you stand?

SEC Rule 10b5-1

More on this story

Back to News

Business

Anthropic Targets $1.4 Trillion IPO Valuation

Anthropic’s planned IPO is facing mounting uncertainty as investors reportedly push to lower its expected valuation from roughly $1.4 trillion–$1.5 trillion, with estimates ranging toward $1 trillion to $1.3 trillion amid a sell-off in AI stocks. Prediction-market odds for a near-term listing have also fallen, and reports say the company could reduce the offering or delay it.

377 sources

World

Total sources

6

Last updatedOct 4, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke baseballnewssource.com · Oct 1, 7:08 PM ETRight +2d6 sources +2d on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

Pope Leo XIV Visits Argentina Amid Milei Tensions

Pope Leo XIV’s visit to Argentina—the first papal visit since 1987—is drawing attention to his ideological divide with President Javier Milei, whose austerity policies the Catholic Church says have harmed the poor. Leo’s first stop at a home for people with disabilities underscores the dispute: the facility says government cuts have halted supplies of medication, special food and diapers.

121 sources

Sponsored

Business

Prime Medicine prices $125 million stock offering

Prime Medicine priced an offering of about 35.7 million new shares at $3.50 each, aiming to raise roughly $125 million before expenses, with underwriters able to buy additional shares. The company will receive the proceeds, but the discounted issuance dilutes existing shareholders; the funds are intended to support its costly development programs.

7 sources